Pathophysiology of chronic graft-versus-host disease and therapeutic targets

Robert Zeiser; Bruce R. Blazar

doi:10.1056/NEJMra1703472

Pathophysiology of chronic graft-versus-host disease and therapeutic targets

Robert Zeiser, Bruce R. Blazar

Research output: Contribution to journal › Review article › peer-review

428 Scopus citations

Abstract

Chronic GVHD, an autoimmune disease that follows allogeneic hematopoietic-cell transplantation, is characterized by infections and debilitating tissue injury leading to irreversible fibrosis. Insights into the pathophysiology of the disease are providing new therapeutic targets.

Original language	English (US)
Pages (from-to)	2565-2579
Number of pages	15
Journal	New England Journal of Medicine
Volume	377
Issue number	26
DOIs	https://doi.org/10.1056/NEJMra1703472
State	Published - Dec 28 2017

Bibliographical note

Publisher Copyright:
© 2017 Massachusetts Medical Society.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1056/NEJMra1703472

OpenUrl availability

Full text

Cite this

@article{ff5b6a0736424cd78ea800ba932837a1,

title = "Pathophysiology of chronic graft-versus-host disease and therapeutic targets",

abstract = "Chronic GVHD, an autoimmune disease that follows allogeneic hematopoietic-cell transplantation, is characterized by infections and debilitating tissue injury leading to irreversible fibrosis. Insights into the pathophysiology of the disease are providing new therapeutic targets.",

author = "Robert Zeiser and Blazar, {Bruce R.}",

note = "Publisher Copyright: {\textcopyright} 2017 Massachusetts Medical Society.",

year = "2017",

month = dec,

day = "28",

doi = "10.1056/NEJMra1703472",

language = "English (US)",

volume = "377",

pages = "2565--2579",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "26",

}

TY - JOUR

T1 - Pathophysiology of chronic graft-versus-host disease and therapeutic targets

AU - Zeiser, Robert

AU - Blazar, Bruce R.

PY - 2017/12/28

Y1 - 2017/12/28

N2 - Chronic GVHD, an autoimmune disease that follows allogeneic hematopoietic-cell transplantation, is characterized by infections and debilitating tissue injury leading to irreversible fibrosis. Insights into the pathophysiology of the disease are providing new therapeutic targets.

AB - Chronic GVHD, an autoimmune disease that follows allogeneic hematopoietic-cell transplantation, is characterized by infections and debilitating tissue injury leading to irreversible fibrosis. Insights into the pathophysiology of the disease are providing new therapeutic targets.

UR - http://www.scopus.com/inward/record.url?scp=85040247029&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040247029&partnerID=8YFLogxK

U2 - 10.1056/NEJMra1703472

DO - 10.1056/NEJMra1703472

M3 - Review article

C2 - 29281578

AN - SCOPUS:85040247029

SN - 0028-4793

VL - 377

SP - 2565

EP - 2579

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 26

ER -

Pathophysiology of chronic graft-versus-host disease and therapeutic targets

Abstract

Bibliographical note

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this